Quick answer: latest quarter results, by ticker or company name

Reported Q: Q1 2025 Rev YoY: +7.5% EPS YoY: +299.5% Move: +0.50%

Walgreens Boots Alliance

WBA

$11.98 0.50%

Exchange NASDAQ Sector Healthcare Industry Medical Pharmaceuticals

Q1 2025

Published: Jan 10, 2025

Company Status Snapshot

Fast view of the latest quarter outcome for WBA

Reported

Report Date

Jan 10, 2025

Quarter Q1 2025

Revenue

39.46B

YoY: +7.5%

EPS

-0.31

YoY: +299.5%

Market Move

+0.50%

Previous quarter: Q4 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

Revenue of $39.46B up 7.5% year-over-year
EPS of $-0.31 increased by 299.5% from previous year
Gross margin of 17.2%
Net income of -265.00M
""The cornerstone of our turnaround is stabilizing the US retail pharmacy business... we're currently exceeding historical script retention rates."" - Tim Wentworth, CEO

WBA

Walgreens Boots Alliance Inc

Period Q1 2025

Currency USD

Report Type Quarterly Earnings

Generated Feb 11, 2026

Executive Summary

In the first quarter of fiscal 2025, Walgreens Boots Alliance Inc (WBA) reported a revenue increase of 6.9% year-on-year on a constant currency basis, totaling $39.46 billion. Despite these positive results, the company faced significant operational challenges, reflected in a net loss of $265 million and a diluted EPS of -$0.31. During the earnings call, CEO Tim Wentworth indicated progress in key areas of financial and operational strategy, specifically in cost management and pharmacy services, while expressing caution about consumer pressures and evolving retail dynamics. Walgreens is focused on optimizing its store footprint to enhance profitability and re-aligning its reimbursement strategies amid a changing healthcare landscape.

Key Performance Indicators

Revenue

Increasing

39.46B

QoQ: 5.09% | YoY: 7.50%

Gross Profit

Increasing

6.78B

17.18% margin

QoQ: 8.41% | YoY: 0.13%

Operating Income

Increasing

-236.00M

QoQ: -75.84% | YoY: 505.13%

Net Income

Increasing

-265.00M

QoQ: -91.18% | YoY: 295.52%

EPS

Increasing

-0.31

QoQ: -91.09% | YoY: 299.48%

Revenue Trend

Margin Analysis

Financial Highlights

### Key Financial Metrics for Q1 2025:
- Revenue: $39.46 billion, up 6.9% YoY
- Net Income: -$265 million, with a net income ratio of -0.67%
- EBITDA: -$236 million, indicating challenges in operational efficiency
- Gross Profit: $6.78 billion; gross profit margin at 17.2%
- EPS (Diluted): -$0.31, reflecting significant operational challenges compared to previous periods

These metrics highlight both the growth potential in pharmacy services and the underlying weaknesses in retail sectors, exacerbated by consumer behavior shifts and market dynamics.

Income Statement

Metric	Value	YoY Change	QoQ Change
Revenue	39.46B	7.50%	5.09%
Gross Profit	6.78B	0.13%	8.41%
Operating Income	-236.00M	505.13%	-75.84%
Net Income	-265.00M	295.52%	-91.18%
EPS	-0.31	299.48%	-91.09%

Key Financial Ratios

Gross Profit Margin

Weak

17.20%

Gross profit margin is below industry norms, profitability concerns

Operating Profit Margin

Weak

-0.01%

Operating margin is below industry norms, profitability concerns

Net Profit Margin

Weak

-0.01%

Net profit margin is below industry norms, profitability concerns

Return on Assets

Weak

0.00%

Return on assets suggests inefficient capital allocation

Return on Equity

Weak

-0.02%

Return on equity suggests inefficient capital allocation

Current Ratio

Concern

0.64

Current ratio below safe levels, potential liquidity risk

Debt to Equity

High Risk

2.75

Debt-to-equity indicates high leverage and elevated financial risk

P/E Ratio

Negative

-7.35x

Negative earnings make P/E ratio not meaningful

Price to Book

Undervalued

0.70x

Trading below book value, potential value opportunity or distressed

Historical Earnings Comparison

Period	Revenue ($M)	EPS ($)	YoY Growth	Report
Q1 2025	39,459.00	-0.31	+7.5%	View
Q4 2024	37,547.00	-3.48	+6.0%	View
Q3 2024	36,351.00	0.40	+2.6%	View
Q2 2024	37,052.00	-6.85	+6.3%	View
Q1 2024	36,707.00	-0.08	+10.0%	View

WBA

Walgreens Boots Alliance

Q4 2024 Report

Walgreens Boots Alliance Inc (WBA) Q4 2024 Financial Results: Navigating Challenges Amid Transformation...

Read full report

WBA

Walgreens Boots Alliance

Q3 2024 Report

Walgreens Boots Alliance Inc (WBA) Q3 2024 Financial Results Report: A Navigational Update in a Challenging Environment...

Read full report

WBA

Walgreens Boots Alliance

Q2 2024 Report

Walgreens Boots Alliance Inc (WBA) Q2 2024 Financial Results: Navigating Challenges with Strategic Depth...

Read full report

WBA

Walgreens Boots Alliance

Q1 2024 Report

Walgreens Boots Alliance Inc (WBA) Q1 2024 Financial Results: Navigating Challenges and Embracing Opportunities...

Read full report

Walgreens Boots Alliance (WBA) Q1 2025 Earnings Report

Company Status Snapshot

Earnings Highlights

Executive Summary

Key Performance Indicators

Revenue Trend

Margin Analysis

Financial Highlights

Income Statement

Key Financial Ratios

Management Insights Available for Members

Peer Comparison Available for Members

Investment Outlook & SWOT Available for Members

Historical Earnings Comparison

More WBA Quarterly Reports

WBA

WBA

WBA

WBA

Q1 2025 Reports in Healthcare Sector

Related Financial Data

Sector Analysis: Healthcare

WBA Full Profile

WBA Financial Statements

Earnings Calendar